Comments

Summit Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SMMTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Summit Therapeutics (SMMT) Forecast

News Earnings Summit Therapeutics (SMMT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Summit Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SMMT | Benzinga

Explore Summit Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SMMT.

Open	$25.39
Close	-
Volume / Avg.	1.08M / 4.05M
Day Range	$24.21 - $25.50
52 Wk Range	2.10 - 36.91
Market Cap	$18.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	23.31%
Days to Cover	3.41

Recent News

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Lekha Gupta

Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

Top performing large-cap stocks in the last week: DUOL, CRWV, THC, CARR, SMMT, AUR, ANET, TT, DXCM, XPO. Most had positive financial results and raised guidance.

Lekha Gupta

Why Is Summit Therapeutics Stock Trading Higher On Monday?

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 trial.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$25.39
Close	-
Volume / Avg.	1.08M / 4.05M
Day Range	$24.21 - $25.50
52 Wk Range	2.10 - 36.91
Market Cap	$18.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	23.31%
Days to Cover	3.41

About Summit Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, a...

Got Questions? Ask

How has SMMT's EPS changed?

What are analysts' targets for SMMT?

What is SMMT's P/S ratio?

What is SMMT's Sharpe ratio?

What is the consensus rating for SMMT?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Who are Summit Therapeutics (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

Summit Therapeutics has a consensus price target of $36.55.

What is the current price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $24.63 last updated May 13, 2025 at 1:02 PM EDT.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.